Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice.
about
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosisInteractions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents.Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosisTreatment options in Invasive Aspergillosis.Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure.Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.Immunocompromised hosts: immunopharmacology of modern antifungals.Stage-specific innate immune recognition of Aspergillus fumigatus and modulation by echinocandin drugs.Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.Combination echinocandin-polyene treatment of murine mucormycosis.Are respiratory complications more likely in patients with pulmonary aspergillosis treated with echinocandins in the setting of neutrophil influx?Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae.Meta-analysis of nebulized amphotericin B to prevent or treat pulmonary aspergillosis in immunosuppressed animals.Analysis of the in vitro activity of human neutrophils against Aspergillus fumigatus in presence of antifungal and immunosuppressive agents.Liposomal treatment of xerostomia, odor, and taste abnormalities in patients with head and neck cancer
P2860
Q30433949-413C7042-7A8D-4B19-92E1-6DC28A0E3327Q34024546-95C85367-0442-49C6-9AA0-C5BDCEAE1D00Q34045435-74D9178B-7890-458A-B94B-F2C00B8E3C2AQ34357504-384CF895-9077-46D1-97EE-30EEB22839C9Q36983268-D1466DA5-0A3D-420A-8955-8944A29B0B91Q37164085-D242AE6C-BB0B-472F-A0A7-69CD073929FAQ37186705-4D3B7EB9-29A9-4C9C-89D6-03E489B8E65FQ37209970-2884B8B1-C406-4FE9-9736-9B69EA9AB396Q37816399-DDA335AB-491B-4639-97D1-F3F21ED4ED05Q38633105-7250E287-7D29-447F-885B-26EF06C80957Q41904884-664ADD7B-C362-48EE-AFEC-265EA36A2E94Q42366766-4F424445-5A28-4BD5-A399-15970AE2FE65Q46577790-15085C3B-F69E-4E0A-A760-B5F61E6A31E5Q46808821-3C418D4D-7D83-4FB4-A6EB-68BA44755402Q50113807-2C3A0CA7-1670-4FA3-A6E5-DB33A06B720EQ58634858-4D563273-7035-44C4-8403-15037517831E
P2860
Pretreatment with empty liposomes attenuates the immunopathology of invasive pulmonary aspergillosis in corticosteroid-immunosuppressed mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pretreatment with empty liposo ...... steroid-immunosuppressed mice.
@ast
Pretreatment with empty liposo ...... steroid-immunosuppressed mice.
@en
type
label
Pretreatment with empty liposo ...... steroid-immunosuppressed mice.
@ast
Pretreatment with empty liposo ...... steroid-immunosuppressed mice.
@en
prefLabel
Pretreatment with empty liposo ...... steroid-immunosuppressed mice.
@ast
Pretreatment with empty liposo ...... steroid-immunosuppressed mice.
@en
P2093
P2860
P356
P1476
Pretreatment with empty liposo ...... steroid-immunosuppressed mice.
@en
P2093
Dimitrios P Kontoyiannis
Georgios Chamilos
Randall A Prince
P2860
P304
P356
10.1128/AAC.01268-06
P407
P577
2006-12-28T00:00:00Z